{
    "Trade/Device Name(s)": [
        "Multigent\u00ae Gentamicin"
    ],
    "Submitter Information": "Seradyn, Inc.",
    "510(k) Number": "K060709",
    "Predicate Device Reference 510(k) Number(s)": [
        "K904226"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCD"
    ],
    "Summary Letter Date": "May 23, 2006",
    "Summary Letter Received Date": "May 24, 2006",
    "Submission Date": "March 14, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.3450"
    ],
    "Regulation Name(s)": [
        "Gentamicin test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Gentamicin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "plastic K2 EDTA tube",
        "glass K3 EDTA tube",
        "glass plasma separator lithium heparin tube",
        "glass sodium heparin tube",
        "glass lithium heparin tube",
        "glass serum separator tube",
        "plastic tube with clot activator",
        "glass tube (no additive)",
        "plastic tube (no additive)"
    ],
    "Instrument(s)/Platform(s)": [
        "Architect C8000 System"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous particle-enhanced turbidimetric immunoassay",
        "Particle agglutination"
    ],
    "Methodologies": [
        "Competitive binding assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Multigent Gentamicin particle-enhanced turbidimetric immunoassay for quantitative determination of gentamicin in human serum or plasma.",
    "Indications for Use Summary": "Quantitative determination of gentamicin in human serum or plasma on the Architect C8000 System, for use in diagnosing and treating gentamicin overdose and monitoring therapy levels.",
    "fda_folder": "Toxicology"
}